[{"address1": "One Amgen Center Drive", "city": "Thousand Oaks", "state": "CA", "zip": "91320-1799", "country": "United States", "phone": "805 447 1000", "fax": "805 447 1010", "website": "https://www.amgen.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Beh\u00e7et's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 28000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert A. Bradway", "age": 62, "title": "Chairman & CEO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 6428574, "exercisedValue": 0, "unexercisedValue": 50993104}, {"maxAge": 1, "name": "Mr. Peter H. Griffith", "age": 66, "title": "Executive VP & CFO", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 3007214, "exercisedValue": 0, "unexercisedValue": 1401880}, {"maxAge": 1, "name": "Dr. David M. Reese M.D.", "age": 62, "title": "Executive VP & CTO", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 3327225, "exercisedValue": 0, "unexercisedValue": 7193319}, {"maxAge": 1, "name": "Mr. Murdo  Gordon", "age": 58, "title": "Executive Vice President of Global Commercial Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 3174030, "exercisedValue": 0, "unexercisedValue": 4835902}, {"maxAge": 1, "name": "Dr. James E. Bradner M.D.", "age": 53, "title": "Executive Vice President of Research & Development", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 4095677, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Esteban  Santos", "age": 57, "title": "Executive Vice President of Operations", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 3006074, "exercisedValue": 0, "unexercisedValue": 12988893}, {"maxAge": 1, "name": "Mr. Matthew C. Busch", "age": 50, "title": "Chief Accounting Officer & VP of Finance", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Skellenger", "title": "Senior VP & Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Howard Y. Chang M.D., Ph.D.", "title": "Senior VP of Global Research & Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Casey  Capparelli", "title": "Executive Director of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 4, "shareHolderRightsRisk": 2, "overallRisk": 3, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.amgen.com/phoenix.zhtml?c=61656&p=irol-IRHome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 347.07, "open": 346.18, "dayLow": 341.815, "dayHigh": 349.225, "regularMarketPreviousClose": 347.07, "regularMarketOpen": 346.18, "regularMarketDayLow": 341.815, "regularMarketDayHigh": 349.225, "dividendRate": 9.66, "dividendYield": 2.8, "exDividendDate": 1770940800, "payoutRatio": 0.72620004, "fiveYearAvgDividendYield": 3.07, "beta": 0.45, "trailingPE": 26.6628, "forwardPE": 15.61928, "volume": 2024242, "regularMarketVolume": 2024242, "averageVolume": 2879338, "averageVolume10days": 2840470, "averageDailyVolume10Day": 2840470, "bid": 343.19, "ask": 343.63, "bidSize": 3, "askSize": 1, "marketCap": 185641205760, "fiftyTwoWeekLow": 261.43, "fiftyTwoWeekHigh": 349.98, "allTimeHigh": 349.98, "allTimeLow": 0.075521, "priceToSalesTrailing12Months": 5.1608577, "fiftyDayAverage": 331.9548, "twoHundredDayAverage": 299.2348, "trailingAnnualDividendRate": 9.39, "trailingAnnualDividendYield": 0.02705506, "currency": "USD", "tradeable": false, "enterpriseValue": 230783205376, "profitMargins": 0.19474001, "floatShares": 537123700, "sharesOutstanding": 538480671, "sharesShort": 14978144, "sharesShortPriorMonth": 14322050, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0278, "heldPercentInsiders": 0.00212, "heldPercentInstitutions": 0.84058, "shortRatio": 5.13, "shortPercentOfFloat": 0.0279, "impliedSharesOutstanding": 538480671, "bookValue": 17.863, "priceToBook": 19.29967, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "earningsQuarterlyGrowth": 0.136, "netIncomeToCommon": 7005000192, "trailingEps": 12.93, "forwardEps": 22.07208, "lastSplitFactor": "2:1", "lastSplitDate": 943228800, "enterpriseToRevenue": 6.416, "enterpriseToEbitda": 14.003, "52WeekChange": 0.22661245, "SandP52WeekChange": 0.14987159, "lastDividendValue": 2.38, "lastDividendDate": 1763683200, "quoteType": "EQUITY", "currentPrice": 344.75, "targetHighPrice": 425.0, "targetLowPrice": 180.0, "targetMeanPrice": 331.5926, "targetMedianPrice": 333.0, "recommendationMean": 2.40625, "recommendationKey": "buy", "numberOfAnalystOpinions": 27, "totalCash": 9445000192, "totalCashPerShare": 17.54, "ebitda": 16481000448, "totalDebt": 54586998784, "quickRatio": 0.823, "currentRatio": 1.28, "totalRevenue": 35970998272, "debtToEquity": 567.491, "revenuePerShare": 66.892, "returnOnAssets": 0.07706, "returnOnEquity": 0.8171, "grossProfits": 25198000128, "freeCashflow": 11408624640, "operatingCashflow": 13125999616, "earningsGrowth": 0.136, "revenueGrowth": 0.124, "grossMargins": 0.70051, "ebitdaMargins": 0.45817003, "operatingMargins": 0.34153, "financialCurrency": "USD", "symbol": "AMGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 424704600000, "postMarketChangePercent": -0.017403208, "postMarketPrice": 344.69, "postMarketChange": -0.05999756, "regularMarketChange": -2.32001, "regularMarketDayRange": "341.815 - 349.225", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2879338, "fiftyTwoWeekLowChange": 83.32001, "fiftyTwoWeekLowChangePercent": 0.3187087, "fiftyTwoWeekRange": "261.43 - 349.98", "fiftyTwoWeekHighChange": -5.230011, "fiftyDayAverageChange": 12.795197, "fiftyDayAverageChangePercent": 0.038544998, "twoHundredDayAverageChange": 45.515198, "twoHundredDayAverageChangePercent": 0.1521053, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "fiftyTwoWeekHighChangePercent": -0.014943742, "fiftyTwoWeekChangePercent": 22.661245, "dividendDate": 1772755200, "earningsTimestamp": 1770152400, "earningsTimestampStart": 1770152400, "earningsTimestampEnd": 1770152400, "earningsCallTimestampStart": 1770154200, "earningsCallTimestampEnd": 1770154200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 12.93, "epsForward": 22.07208, "epsCurrentYear": 21.27441, "priceEpsCurrentYear": 16.204914, "corporateActions": [], "postMarketTime": 1769214712, "regularMarketTime": 1769202002, "exchange": "NMS", "messageBoardId": "finmb_24816", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.668455, "regularMarketPrice": 344.75, "shortName": "Amgen Inc.", "longName": "Amgen Inc.", "marketState": "CLOSED", "displayName": "Amgen", "trailingPegRatio": 1.0776, "__fetch_time": "2026-01-24"}]